Prelude Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-10,706
| Closed | -$464K | – | 1368 |
|
2024
Q1 | $464K | Sell |
10,706
-6,700
| -38% | -$290K | 0.02% | 598 |
|
2023
Q4 | $800K | Buy |
17,406
+1,000
| +6% | +$46K | 0.05% | 295 |
|
2023
Q3 | $376K | Buy |
+16,406
| New | +$376K | 0.02% | 468 |
|
2019
Q3 | – | Sell |
-365
| Closed | -$8K | – | 1521 |
|
2019
Q2 | $8K | Buy |
+365
| New | +$8K | ﹤0.01% | 1051 |
|